Table 1.
Characteristics of RA patients studied.
| RA (n = 29) | |
|---|---|
| Age, years | 54.4 (27−77) |
| Female, n (%) | 26 (89.7 %) |
| RA activity, n (DAS28-ESR) | 5 (2.6−3.2) |
| 18 (3.2−5.1) | |
| 6 (>5.1) | |
| ESR (mm/h) | 49.1 (7−145) |
| WBC (*109/L) | 6.57 (2.8−11.47) |
| Hb (g/L) | 104.3 (40−136) |
| Plt (/μL) | 285.7 (133−498) |
| IgG (g/L) | 16.35 (6.72−42.66) |
| IgM (g/L) | 1.44 (0.62−4.98) |
| IgA (g/L) | 3.48 (0.45−4.92) |
| C3 (g/L) | 1.24 (0.7−1.75) |
| C4 (g/L) | 0.27 (0.09−0.45) |
| C1q (g/L) | 205.5 (103−283) |
| R-IgG (U/mL) | 66.2 (13.5−200.1) |
| R-IgM (U/mL) | 57.6 (9.4−211.6) |
| CCP (U/mL) | 67.8 (7.1−215.3) |
2.6−3.2, Low disease activity; 3.2−5.1, Moderate disease activity; >5.1, High disease activity.